Researchers at the University of Cologne’s Center for Molecular Medicine Cologne discovered that blocking caspase-8 can trigger cell death in KRAS-mutant pancreatic tumors, a common type of pancreatic cancer. This finding is significant because it identifies a potential therapeutic target for treating pancreatic cancer, which currently has limited treatment options and high mortality rates. Further research could lead to new drugs that inhibit caspase-8 specifically in tumor cells.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
2
Ali NematiWritten by Ali
